In contrast, the extent of GFAP expression seems to correspond to the severity of astroglial activation and neurodegeneration in various neuroinflammatory-based disorders, including Alzheimer’s disease, Parkinson’s disease, HIV dementia and multiple sclerosis (Sadick and Liddelow 2019). This evidence concerns the gene GFAP and Parkinson disease.